Nurse Practitioner, Family · Grandfield, OK
NPI
1801081658
Since 2007
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
117 S Bridge Blvd
Grandfield, OK, 73546
Phone (580) 560-5715
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
1,201 services
Medicare patients, 2024
145
Average age 71
Drug cost, 2024
$953K
6,483 prescriptions
Company payments, 2025
$88.93
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kenda L Dean was code 99214 (office e&m - established), 460 times for 125 patients. In total Kenda L Dean billed 1,201 services in 43 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 460 | 125 | $71.64 | $33K |
| 99213 Office E&M - Established | Office | 137 | 81 | $48.91 | $6,701 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 106 | 37 | $0.73 | $76.88 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 106 | 36 | $0.09 | $9.43 |
| 96372 Injection Administration | Office | 99 | 47 | $8.51 | $842 |
| 81003 Clinical Chemistry | Office | 61 | 36 | $2.20 | $134 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 53 | 24 | $0.57 | $30 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 29 | 14 | $0.36 | $10.3 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 21 | 21 | $101.89 | $2,140 |
| 87811 Immunoassay | Office | 16 | 12 | $40.55 | $649 |
| 83036 Blood Count | Office | 15 | 12 | $9.52 | $143 |
By year: 2022 $34K for 1,058 services; 2023 $33K for 647 services; 2024 $47K for 1,201 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 61 | 36 | $2.20 | $134 |
| 87811 Immunoassay | 16 | 12 | $40.55 | $649 |
| 83036 Blood Count | 15 | 12 | $9.52 | $143 |
Medicare prescription drug claims, 2024
In 2024, the drug Kenda L Dean prescribed most often to Medicare patients was Atorvastatin Calcium, with 223 prescriptions and refills. In total Kenda L Dean wrote 6,483 Medicare prescriptions that cost $953K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 223 | 456 | 52 | $2,052 |
| Levothyroxine Sodium Generic | 187 | 452 | 52 | $2,484 |
| Amlodipine Besylate Generic | 183 | 383 | 40 | $1,208 |
| Metoprolol Succinate Generic | 145 | 355 | 34 | $2,081 |
| Lisinopril Generic | 142 | 336 | 38 | $1,246 |
| Omeprazole Generic | 141 | 320 | 33 | $2,226 |
| Alprazolam Generic | 141 | 141 | 23 | $1,116 |
| Losartan Potassium Generic | 138 | 317 | 31 | $1,741 |
| Pantoprazole Sodium Generic | 134 | 302 | 40 | $1,517 |
| Montelukast Sodium Generic | 123 | 329 | 40 | $1,902 |
| Trulicity Dulaglutide | 104 | 104 | 15 | $103K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 104 | 124 | 33 | $3,125 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 100 | 100 | 15 | $3,158 |
| Jardiance Empagliflozin | 98 | 118 | 14 | $68K |
| Ozempic Semaglutide | 96 | 100 | 12 | $95K |
Brand drugs: 1,090 claims; generic drugs: 5,345 claims; opioid claims: 195.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kenda L Dean $88.93 ($88.93 in general payments such as food, travel and fees) from 2 companies. The largest payer was ANI Pharmaceuticals, Inc. with $68.94.
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. ANIP | 3 | $68.94 |
| Xeris Pharmaceuticals, Inc. | 1 | $19.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.